Assenagon Asset Management S.A. Takes $1.72 Million Position in Maximus, Inc. $MMS

Assenagon Asset Management S.A. bought a new position in Maximus, Inc. (NYSE:MMSFree Report) in the 2nd quarter, Holdings Channel.com reports. The fund bought 31,975 shares of the health services provider’s stock, valued at approximately $1,719,000.

Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Maximus in the 4th quarter worth about $60,393,000. River Road Asset Management LLC lifted its stake in shares of Maximus by 236.1% during the 4th quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock worth $71,064,000 after purchasing an additional 578,326 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in Maximus by 218.4% in the fourth quarter. Goldman Sachs Group Inc. now owns 583,627 shares of the health services provider’s stock valued at $50,379,000 after acquiring an additional 400,315 shares in the last quarter. Boston Partners grew its stake in Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider’s stock worth $88,236,000 after buying an additional 308,892 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of Maximus by 493.0% during the fourth quarter. The Manufacturers Life Insurance Company now owns 342,266 shares of the health services provider’s stock worth $29,544,000 after buying an additional 284,548 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

MMS has been the subject of several analyst reports. Weiss Ratings cut shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, May 20th. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Zacks Research lowered Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Maximus currently has a consensus rating of “Reduce”.

View Our Latest Analysis on MMS

Maximus Price Performance

Maximus stock opened at $55.24 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The stock has a market capitalization of $2.89 billion, a PE ratio of 8.16 and a beta of 0.59. Maximus, Inc. has a 12 month low of $52.73 and a 12 month high of $100.00. The business has a 50 day simple moving average of $58.05 and a 200-day simple moving average of $65.96.

Maximus (NYSE:MMSGet Free Report) last released its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping the consensus estimate of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the firm earned $2.16 EPS. The business’s revenue for the quarter was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities analysts predict that Maximus, Inc. will post 8.01 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be paid a dividend of $0.33 per share. The ex-dividend date is Friday, August 14th. This represents a $1.32 annualized dividend and a yield of 2.4%. Maximus’s dividend payout ratio is 19.50%.

Maximus Company Profile

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Featured Articles

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.